Development of a Patient Decision Aid for Targeted Therapy for Relapsed Ovarian Cancer

Background: Patients with recurrent ovarian cancer often face difficulty choosing treatment such as chemotherapy or targeted therapy. Aim: This study aimed to design this patient decision aid (PDA), which presents therapeutic efficacy and cost to help patients make appropriate and personalized treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Hung-Che Chien, Po-Chao Hsu, Yi-Hsin Lin, Yu-Chi Wang, Mu-Hsien Yu, Chuang-Yen Huang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-03-01
Series:Journal of Medical Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jmedsci.jmedsci_225_24
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Patients with recurrent ovarian cancer often face difficulty choosing treatment such as chemotherapy or targeted therapy. Aim: This study aimed to design this patient decision aid (PDA), which presents therapeutic efficacy and cost to help patients make appropriate and personalized treatment decisions. Methods: A PDA was developed according to the International PDA Standards (IPDAS), and α and β tests were conducted on 14 healthcare professionals and 10 public representatives as test participants. Results: Using a Likert scale, the public representatives gave positive comments about the advantages and disadvantages of the PDA’s fair presentation of treatment choices and promotion of doctor–patient shared decision-making (SDM) (average score, 3.7–4.5 points). Similarly, the healthcare professionals were optimistic that this PDA could help patients more easily understand their choices (average score, 4.3–4.4 points). The average anxiety level before and after PDA use decreased from 7.5–5 points (scale, 1–10). Conclusion: According to this newly developed PDA, doctors and the public play a pivotal role: the latest medical literature and treatment options are kept up with, and the most correct and updated information is provided for use by doctors and patients. Therefore, the PDA design’s original intention and purpose were fulfilled.
ISSN:1011-4564
2542-4939